AAAAAA

   
Results: 1-15 |
Results: 15
ETON and NRSWA - A summary of the changes and challenges affecting street works
Authors: Patrick, D
Citation: D. Patrick, ETON and NRSWA - A summary of the changes and challenges affecting street works, J INST BR T, 2, 2001, pp. 83-87
Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs
Authors: Ochnio, JJ Patrick, D Ho, M Talling, DN Dobson, SR
Citation: Jj. Ochnio et al., Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs, CAN MED A J, 165(3), 2001, pp. 293-297
International development of the quality of life in depression scale (QLDS)
Authors: McKenna, SP Doward, LC Kohlmann, T Mercier, C Niero, M Paes, M Patrick, D Ramirez, N Thorsen, H Whalley, D
Citation: Sp. Mckenna et al., International development of the quality of life in depression scale (QLDS), J AFFECT D, 63(1-3), 2001, pp. 189-199
Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: Studies with DFP, a cyclooxygenase-2 inhibitor
Authors: Nicoll-Griffith, DA Silva, JM Chauret, N Day, S Leblanc, Y Roy, P Yergey, JA Dixit, R Patrick, D
Citation: Da. Nicoll-griffith et al., Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: Studies with DFP, a cyclooxygenase-2 inhibitor, DRUG META D, 29(2), 2001, pp. 159-165
Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors
Authors: Huber, HE Robinson, RG Watkins, A Nahas, DD Abrams, MT Buser, CA Lobell, RB Patrick, D Anthony, NJ Dinsmore, CJ Graham, SL Hartman, GD Lumma, WC Williams, TM Heimbrook, DC
Citation: He. Huber et al., Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors, J BIOL CHEM, 276(27), 2001, pp. 24457-24465
Postscript - The remaining questions
Authors: Patrick, D Chiang, YP
Citation: D. Patrick et Yp. Chiang, Postscript - The remaining questions, MED CARE, 38(9), 2000, pp. 209-210
Noncommutative symmetric algebras of two-sided vector spaces
Authors: Patrick, D
Citation: D. Patrick, Noncommutative symmetric algebras of two-sided vector spaces, J ALGEBRA, 233(1), 2000, pp. 16-36
The transformation of 'Torah' from scribal advice to law
Authors: Patrick, D
Citation: D. Patrick, The transformation of 'Torah' from scribal advice to law, CATH BIBL Q, 62(4), 2000, pp. 723-724
Care for depression in HMO patients aged 65 and older
Authors: Unutzer, J Simon, G Belin, TR Datt, M Katon, W Patrick, D
Citation: J. Unutzer et al., Care for depression in HMO patients aged 65 and older, J AM GER SO, 48(8), 2000, pp. 871-878
The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor
Authors: Prasit, P Wang, Z Brideau, C Chan, CC Charleson, S Cromlish, W Ethier, D Evans, JF Ford-Hutchinson, AW Gauthier, JY Gordon, R Guay, J Gresser, M Kargman, S Kennedy, B Leblanc, Y Leger, S Mancini, J O'Neill, GP Ouellet, M Percival, MD Perrier, H Riendeau, D Rodger, I Tagari, P Therien, M Vickers, P Wong, E Xu, LJ Young, RN Zamboni, R Boyce, S Rupniak, N Forrest, N Visco, D Patrick, D
Citation: P. Prasit et al., The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor, BIOORG MED, 9(13), 1999, pp. 1773-1778
Teratogenic effects of the endothelin receptor antagonist L-753,037 in therat. (vol 13, pg 15, 1999)
Authors: Spence, S Anderson, C Cukierski, M Patrick, D
Citation: S. Spence et al., Teratogenic effects of the endothelin receptor antagonist L-753,037 in therat. (vol 13, pg 15, 1999), REPROD TOX, 13(3), 1999, pp. 237-237
Teratogenic effects of the endothelin receptor antagonist L-753,037 in therat
Authors: Spence, S Anderson, C Cukierski, M Patrick, D
Citation: S. Spence et al., Teratogenic effects of the endothelin receptor antagonist L-753,037 in therat, REPROD TOX, 13(1), 1999, pp. 15-29
Clinical and histologic evaluation of submerged and nonsubmerged hydroxyapatite-coated implants: A preliminary study in dogs
Authors: Kohal, RJ De LaRosa, M Patrick, D Hurzeler, MB Caffesse, RG
Citation: Rj. Kohal et al., Clinical and histologic evaluation of submerged and nonsubmerged hydroxyapatite-coated implants: A preliminary study in dogs, INT J O M I, 14(6), 1999, pp. 824-834
Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles
Authors: Chan, CC Boyce, S Brideau, C Charleson, S Cromlish, W Ethier, D Evans, J Ford-Hutchinson, AW Forrest, MJ Gauthier, JY Gordon, R Gresser, M Guay, J Kargman, S Kennedy, B Leblanc, Y Leger, S Mancini, J O'Neill, GP Ouellet, M Patrick, D Percival, MD Perrier, H Prasit, P Rodger, I Tagari, P Therien, M Vickers, P Visco, D Wang, Z Webb, J Wong, E Xu, LJ Young, RN Zamboni, R Riendeau, D
Citation: Cc. Chan et al., Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles, J PHARM EXP, 290(2), 1999, pp. 551-560
Studies on the 'Book of Numbers': Narrative, history and law in Numbers-XIII,1-XX,13
Authors: Patrick, D
Citation: D. Patrick, Studies on the 'Book of Numbers': Narrative, history and law in Numbers-XIII,1-XX,13, CATH BIBL Q, 61(4), 1999, pp. 733-734
Risultati: 1-15 |